Validation of a SNP-based non-invasive prenatal test to detect the fetal 22q11.2 deletion in maternal plasma samples

• Harini Ravi,

  Roles Conceptualization, Validation

  Affiliation Natera, Inc., San Carlos, CA, United States of America

  ⨯
• Gabriel McNeill,

  Roles Formal analysis, Validation

  Affiliation Natera, Inc., San Carlos, CA, United States of America

  ⨯
• Shruti Goel,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Natera, Inc., San Carlos, CA, United States of America

  ⨯
• Steven D. Meltzer,

  Roles Resources

  Affiliation The Woman’s Hospital of Texas, Houston, TX, United States of America

  ⨯
• Nathan Hunkapiller,

  Roles Methodology, Supervision

  Affiliation Natera, Inc., San Carlos, CA, United States of America

  ⨯
• Allison Ryan,

  Roles Formal analysis, Methodology, Supervision, Validation

  Affiliation Natera, Inc., San Carlos, CA, United States of America

  ⨯
• Brynn Levy,

  Roles Investigation, Writing – review & editing

  Affiliation Department of Pathology and Cell Biology, Columbia University, New York, NY, United States of America

  ⨯
• Zachary P. Demko

  Roles Project administration, Supervision, Writing – review & editing

  * E-mail: zdemko@natera.com

  Affiliation Natera, Inc., San Carlos, CA, United States of America

  ⨯